Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)

• Status: Completed
• Trial end date: 2008-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Javelin Pharmaceuticals
• Treatments: Ketamine; Mometasone Furoate

Criteria

Inclusion Criteria:

• healthy adults

• nonsmoker

• no drug use

Exclusion Criteria:

• nasal abnormalities

• airway abnormalities